Patent · US Active

Spiroindolinone pyrrolidines

US8088815B2 · kind B2 · utility

32Cited by
9References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 4, 2010
Grant dateJan 3, 2012
Priority date—
Expiry dateNov 4, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There are provided compounds of the formulawherein X, Y and R1 to R8 are described herein along with the enantiomers, pharmaceutically acceptable salts and esters thereof. The compounds are useful as anticancer agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.